Navigation Links
Henry Schein Chairman Of The Board & CEO Receives 'Centennial Recognition Award' For Extraordinary Commitment To The National Dental Association
Date:8/2/2013

icient practices and delivering high-quality care.  Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items.

The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.  Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 24 countries.  The Company's sales reached a record $8.9 billion in 2012, and have grown at a compound annual rate of 17 percent since Henry Schein became a public company in 1995.  For more information, visit the Henry Schein Web site at www.henryschein.com.


'/>"/>
SOURCE Henry Schein, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Henry Schein to Open NASDAQ Stock Market to Celebrate Rebranding of U.S. Animal Health Business
2. Henry Schein To Webcast Second Quarter 2013 Conference Call On Tuesday, August 6 At 10:00 a.m. ET
3. Henry Schein Dental And American Dental Hygienists Association Host "Dream Center" To Mark 100th Anniversary Of Profession
4. Henry Schein To Present At Three Conferences In May
5. Henry Schein Named As One Of FORTUNEs Largest 300 Corporations In America
6. Henry Schein To Webcast First Quarter 2013 Conference Call On Tuesday, May 7 At 10:00 a.m. ET
7. Henry Schein Secures $300 Million Of Committed Financing
8. Henry Schein To Open NASDAQ Stock Market in Celebration of FDI World Dental Federations "World Oral Health Day"
9. Henry Schein Named to FORTUNEs List of Most Admired Companies for 12th Consecutive Year
10. Henry Schein to Present at the 2013 Barclays Global Healthcare Conference
11. Optimer Pharmaceuticals Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... DENVER , Aug. 28, 2014 ... a two-year investment into this game-changing method for ... Today, clinical trials target specific cancers, ... be contributing factors for the cancer, in the ... is that this information may not be well ...
(Date:8/28/2014)... 28, 2014  In anticipation of the upcoming MEDevice ... available for the first time. Industry Overview: Medtech & ... offers a snapshot of San Diego,s ... from the latest employment statistics to current venture capital investment ... Diego such a vital part of the global ...
(Date:8/28/2014)... MINNEAPOLIS , Aug. 28, 2014 Nonin ... a leader in noninvasive medical monitoring, today announced that ... Nonin Model 3231 OEM/eHealth finger pulse oximeter for use ... finger pulse oximeter plugs into a telemedicine hub or ... and pulse rate in pediatric to adult patients. The ...
Breaking Medicine Technology:Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches 2New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... Weiss, Director of Maryland Laser, Skin and Vein,Institute, ... BALTIMORE, Oct. 2 Robert Weiss, M.D., board ... U.S. to offer his,patients DOT Therapy (Dermal Optical ... Dr. Weiss is an,internationally renowned dermatologist, who is ...
... Biotechnologies AB and Dyax,Corp. (NASDAQ: DYAX ) ... a,collaboration to discover and to develop therapeutic ... inflammatory diseases., The collaboration follows the ... Professors Frostegard and de Faire of the ...
Cached Medicine Technology:DOT Therapy: Newest Breakthrough Technology in Laser Skin Resurfacing 2Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 2Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 3Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 4
(Date:8/28/2014)... (HealthDay News) -- A potentially deadly fungus that has ... grows on trees, a new study finds. The ... they were tipped off to the finding by a ... gattii fungus triggers infections of the lungs and ... all AIDS-related deaths, the researchers noted. They found that ...
(Date:8/28/2014)... control measures which have been adopted by most ... west Africa are unnecessary, and may heighten panic ... of a new letter, published in The Lancet ... the University of Valencia in Spain, and colleagues. ... infected patients, blood, vomit, faeces and other secretions, both ...
(Date:8/28/2014)... Bethesda, MD FASEB MARC (Maximizing Access to Research ... the American Society for Bone and Mineral Research from ... are meant to promote the entry of students, post ... of the basic science community and to encourage the ... Bone and Mineral Research. This year MARC conferred ...
(Date:8/28/2014)... (Aug. 28, 2014) Solid-head power toothbrushes ... to researchers at The University of Texas Health ... The results of the study are published in ... Hygiene. Lead author and professor at the UTHealth ... notes that microbial counts were lower in the ...
(Date:8/28/2014)... Tampa, Florida (PRWEB) August 28, 2014 ... into the Healthbox tech accelerator program in Tampa. ... help seven innovative healthcare companies grow and achieve their ... this Tuesday, August 16th, at their launch event at ... healthcare innovation professionals. , Co-founder Matt Schneider commented on ...
Breaking Medicine News(10 mins):Health News:California Trees Harbor Fungus Deadly to People With HIV 2Health News:The Lancet: Respiratory infection controls being used for ebola patients are unnecessary and may contribute to public panic 2Health News:UTHealth researchers find up to 3,000 times the bacterial growth on hollow-head toothbrushes 2Health News:Save On Medical Accepted Into Healthbox Accelerator Program 2
... become one of the major public health problems in developed ... a researcher at the University of Zaragoza (UNIZAR), tells SINC. ... than two hours of television per day. At weekends, this ... July issue of the journal Preventive Medicine , show ...
... HealthDay Reporter , THURSDAY, Sept. 16 (HealthDay News) -- ... -- also known as cryotherapy -- works better than applying ... No one treatment cured more than half of cases, ... needed, experts say. The new finding is a bit ...
... Round Rock, Texas is recruiting patients for a Phase ... recurrence in previously treated patients. The trial will ... Immunotherapeutic (ASCI) for the treatment of Non-Small Cell Lung ... Cell LunG Cancer Immunotherapy) study is expected to be ...
... Jenifer Goodwin HealthDay Reporter , THURSDAY, Sept. 16 ... risk of colorectal cancer, new research finds. Prior research ... colon cancer. But this study is among the first to ... side effects such as gastrointestinal bleeding -- may also be ...
... patients develop post-traumatic stress syndrome (PTSD) after the trauma ... to be exacerbated by delusional or fragmentary memories of ... writing in BioMed Central,s open access journal Critical ... relatives make a diary for patients, featuring information about ...
... significant and lasting relief for patients with myelofibrosis, a ... University of Texas MD Anderson Cancer Center report in ... . Myelofibrosis is caused by the accumulation of ... scarring the bone marrow and limiting its ability to ...
Cached Medicine News:Health News:Teenagers are more sedentary on weekends 2Health News:For Common Warts, Freezing Therapy Works Best: Study 2Health News:For Common Warts, Freezing Therapy Works Best: Study 3Health News:Low-Dose Aspirin May Reduce Colon Cancer Risk 2Health News:Low-Dose Aspirin May Reduce Colon Cancer Risk 3Health News:Intensive care diaries protect patients from PTSD 2Health News:JAK inhibitor provides rapid, durable relief for myelofibrosis patients 2Health News:JAK inhibitor provides rapid, durable relief for myelofibrosis patients 3
... Arthrotek® Precision Hand Instruments were developed ... tactile feel, while still having an instrument ... spaces without the fear of the bending ... designed and manufactured to conform to the ...
... Hand Instruments were developed in surgeon's desire ... still having an instrument with the strength ... fear of the bending or breaking. Arthrotek ... to conform to the surgeon's hand. This ...
... were developed in surgeon's desire to have ... an instrument with the strength to maneuver ... the bending or breaking. Arthrotek Hand Instruments ... to the surgeon's hand. This new generation ...
... Arthrotek® Precision Hand Instruments were developed ... tactile feel, while still having an instrument ... spaces without the fear of the bending ... designed and manufactured to conform to the ...
Medicine Products: